☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
EADV 2021
PharmaShots Interview: Janssen's Lloyd Miller Shares Insight on the Data of Tremfya (guselkumab) Presented at EADV 2021
November 10, 2021
Sanofi Presents Results of Amlitelimab (KY1005) in P-IIa Study for the Treatment of Moderate-To-Severe Atopic Dermatitis at EADV 2...
October 1, 2021
Load more...
Back to Home
